The current manuscript is the second update of the original Practical Guide, published in
2013 [Heidbuchel et al. European Heart Rhythm Association Practical Guide on the use of …

Background: Stroke reduction with direct oral anticoagulants (DOACs) in atrial fibrillation
(AF) is dependent on adherence and persistence in the real-world setting. Individual study …

Introduction Medications cannot exert their effect if not taken as prescribed by patients. Our
objective was to summarise the observational evidence on adherence to oral anticoagulants …

Abstract The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to
reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare …

Pulmonary embolism (PE) is a major cause of morbidity and mortality in the United States.
Although new therapeutic tools and strategies have recently been developed for the …

Background Despite simpler regimens than vitamin K antagonists (VKAs) for stroke
prevention in atrial fibrillation (AF), adherence (taking drugs as prescribed) and persistence …

Objective The aim of this study was to examine the association between medication
adherence and illness perceptions, and to explore the factors associated with poor …

Background In patients with atrial fibrillation, incomplete adherence to anticoagulants
increases risk of stroke. Non-warfarin oral anticoagulants (NOACs) are expensive; we …

Background In contrast to vitamin K antagonists (VKA), direct oral anticoagulants (DOAC's)
are not strictly monitored and dose titrated by anticoagulation clinics in the Netherlands. This …

Background Direct oral anticoagulants (DOACs) are widely used in patients with nonvalvular
atrial fibrillation for stroke prevention. However, longterm adherence to DOACs and clinical …